Library of Congress |

Library of Congress

Matches in Library of Congress for { <http://lccn.loc.gov/2013013054> ?p ?o. }

Showing items 1 to 29 of 29 with 100 items per page.

2013013054 contributor B12719933.
2013013054 created "c2013.".
2013013054 date "2013".
2013013054 date "c2013.".
2013013054 dateCopyrighted "c2013.".
2013013054 description "Includes bibliographical references and index.".
2013013054 description "Machine generated contents note: Section 1 Dermotology and Oncology 1 Epidemiology and Burden of Disease / Beth McLellan and Mario E. Lacouture -- 2 The History of Supportive Oncodermatology / Yevgeniy Balagula1, Steven T. Rosen and Mario E. Lacouture -- 3 Structure and Function of the Integumentary System and the Dermatology Lexicon / Emmy Garber and Amit Garg -- Types of dermatologic reactions / Raed O. Alhusayen, Sandra R. Knowles and Neil H. Shear -- 5 Grading Dermatologic Adverse Events on Clinical Trials using CTCAE v4.0 / Alice Chen, Asha Acharya and Ann Setser -- 6 Psychosocial Issues in Oncology: Clinical management of psychosocial distress, health-related quality of life and special considerations in dermatologic oncology / Lynne I. Wagner and David Cella -- 7 Dermatopathology / James L. Troy and Molly Hinshaw -- Section 2 8 Cancer-Related Dermatologic Disorders / Cindy England Owen and Jeffrey P. Callen -- Section 3 Dermatologic Conditions During Cancer Therapy 9 ORAL MUCOSAL COMPLICATIONS OF CANCER THERAPY / Stephen T. Sonis -- 10 Hair Disorders Associated with Anticancer Agents / Caroline Yeager and Elise A. Olsen -- 11 NAIL ABNORMALITIES IN ONCOLOGY PRACTICE / Robert Baran, Bernard Fouilloux and Caroline Robert -- 12 Pruritus / Tejesh Patel and Gil Yosipovitch -- 13 Management Options for Hot Flashes in Cancer Patients / Amanda R. Moraska and Charles L. Loprinzi -- Section 4 Skin toxicities due to chemotherapy 14 Alkylating agents (Busulfan, ThioTEPA, Mechlorethamine, Melphalan, Chlorambucil, cyclophosphamide, ifosfamide, carmustine, streptozocin, dacarbazine, temozolomide, etoposide,BCNU) / Elisabeth Livingstone, Lisa Zimmer, Larissa Schottler, Dirk Schadendorf1 -- 5 Antimetabolite Reactions (Methotrexate, pemetrexed, capecitabine, cytarabine, gemcitabine, 6MP, 6-TG, fludarabine, cladribine) / Emily Y. Chu and Heidi H. Kong -- 16 Topoisomerase-interacting agents (irinotecan, topotecan, doxorubicin, daunorubicin,epirubicin, idarubicin, mitoxantrone, dactinomycin, etoposide, teniposide) / Tomas Skacel, Roger von Moos and Reinhard Dummer -- 17 Epidermal Growth Factor Receptor Inhibitor Reactions / Yevgeniy Balagula and Mario E. Lacouture -- 18 Small Molecule Kinase Inhibitors / Caroline Robert, Vincent Sibaud and Christine Mateus -- 19 Antimicrotubule agents (Paclitaxel, docetaxel, albumin-bound paclitaxel, vincristine, vinblastine, vi-norelbine, estramustine) / Claus Garbe -- 20 Histone Deacetylase Inhibitors (HDAC inhibitors) Proteasome inhibitors Demethylating Agents Arsenicals Retinoids / Najla Al-Dawsari, Shannon Campbell and Francine Foss -- 21 Miscellaneous Reactions (L-Asparaginase, bleomycin, thalidomide, lenalidomide) / Katharina C. Kaehler, Christine B. Boers-Doets, Mario E. Lacouture and Axel Hauschild -- 22 Skin toxicities due to biotherapy (Interferon-[alpha]2b, Interleukin-2) / Axel Hauschild, Katharina Kaehler and Mario Lacouture -- 23 Monoclonal antibodies / Caroline Robert -- 24 Endocrine Agents / Katherine Szyfelbein and Mario Lacouture -- 25 Agents for the management of hematologic reactions: epotein alpha, darbopoetin, G-CSF, GM-CSF; oprelvekin; low molecular weight heparin; warfarin. / Mee-young Lee and Caroline C. Kim -- 26 RDERMATOLOGICAL PRINCIPLES AND PRACTICE IN ONCOLOGY / Rebecca Wong and Zahra Kassam -- 27 Hematopoietic stem cell transplantation and graft-versus-host disease / Stephanie Hu and Jonathan Cotliar -- 28 Extravasation Reactions / Seppo W. Langer -- 29 Topical Anticancer Therapies / Patricia L. Myskowski -- 30 Life-threatening (Serious) Dermatologic Adverse Events / Milan Anadkat -- 31 Dermatologic infections / Yevgeniy Balagula, Mario E. Lacouture and James I. Ito Section 5 -- 32 Late Dermatologic Conditions / Jennifer Namchoi Section 6 Dermatologic Practice in Oncology 33 Management Algorithms for Dermatologic Adverse Events / Alyx Rosen, Iris Amitay-Laish and Mario E. Lacouture -- 34 Dermatological therapeutics and formulations / Judy H. Borovicka, Jennifer R.S. Gordon, Ann Cameron Haley and Dennis P. West35 Dermatological Techniques and Procedures / Kishwer Nehal, Erica Lee and Robert Eilers -- 36 Appearance-Related Concerns in the Cancer Patient / Amy J. Derick.".
2013013054 extent "p. ;".
2013013054 identifier "9780470621882 (hardback : alk. paper)".
2013013054 identifier "9781118590607 (pub)".
2013013054 identifier "9781118590614 (PDF)".
2013013054 identifier "9781118590621 (Mobi)".
2013013054 identifier "9781118590638 (online product)".
2013013054 issued "2013".
2013013054 issued "c2013.".
2013013054 language "eng".
2013013054 publisher "Hoboken, N.J. : Wiley-Blackwell,".
2013013054 subject "616.99/477 23".
2013013054 subject "Antineoplastic Agents adverse effects.".
2013013054 subject "Neoplasms complications.".
2013013054 subject "RC280.S5".
2013013054 subject "Skin Care nursing.".
2013013054 subject "Skin Diseases etiology.".
2013013054 subject "Skin Diseases psychology.".
2013013054 subject "Skin Manifestations.".
2013013054 subject "WR 140".
2013013054 tableOfContents "Machine generated contents note: Section 1 Dermotology and Oncology 1 Epidemiology and Burden of Disease / Beth McLellan and Mario E. Lacouture -- 2 The History of Supportive Oncodermatology / Yevgeniy Balagula1, Steven T. Rosen and Mario E. Lacouture -- 3 Structure and Function of the Integumentary System and the Dermatology Lexicon / Emmy Garber and Amit Garg -- Types of dermatologic reactions / Raed O. Alhusayen, Sandra R. Knowles and Neil H. Shear -- 5 Grading Dermatologic Adverse Events on Clinical Trials using CTCAE v4.0 / Alice Chen, Asha Acharya and Ann Setser -- 6 Psychosocial Issues in Oncology: Clinical management of psychosocial distress, health-related quality of life and special considerations in dermatologic oncology / Lynne I. Wagner and David Cella -- 7 Dermatopathology / James L. Troy and Molly Hinshaw -- Section 2 8 Cancer-Related Dermatologic Disorders / Cindy England Owen and Jeffrey P. Callen -- Section 3 Dermatologic Conditions During Cancer Therapy 9 ORAL MUCOSAL COMPLICATIONS OF CANCER THERAPY / Stephen T. Sonis -- 10 Hair Disorders Associated with Anticancer Agents / Caroline Yeager and Elise A. Olsen -- 11 NAIL ABNORMALITIES IN ONCOLOGY PRACTICE / Robert Baran, Bernard Fouilloux and Caroline Robert -- 12 Pruritus / Tejesh Patel and Gil Yosipovitch -- 13 Management Options for Hot Flashes in Cancer Patients / Amanda R. Moraska and Charles L. Loprinzi -- Section 4 Skin toxicities due to chemotherapy 14 Alkylating agents (Busulfan, ThioTEPA, Mechlorethamine, Melphalan, Chlorambucil, cyclophosphamide, ifosfamide, carmustine, streptozocin, dacarbazine, temozolomide, etoposide,BCNU) / Elisabeth Livingstone, Lisa Zimmer, Larissa Schottler, Dirk Schadendorf1 -- 5 Antimetabolite Reactions (Methotrexate, pemetrexed, capecitabine, cytarabine, gemcitabine, 6MP, 6-TG, fludarabine, cladribine) / Emily Y. Chu and Heidi H. Kong -- 16 Topoisomerase-interacting agents (irinotecan, topotecan, doxorubicin, daunorubicin,epirubicin, idarubicin, mitoxantrone, dactinomycin, etoposide, teniposide) / Tomas Skacel, Roger von Moos and Reinhard Dummer -- 17 Epidermal Growth Factor Receptor Inhibitor Reactions / Yevgeniy Balagula and Mario E. Lacouture -- 18 Small Molecule Kinase Inhibitors / Caroline Robert, Vincent Sibaud and Christine Mateus -- 19 Antimicrotubule agents (Paclitaxel, docetaxel, albumin-bound paclitaxel, vincristine, vinblastine, vi-norelbine, estramustine) / Claus Garbe -- 20 Histone Deacetylase Inhibitors (HDAC inhibitors) Proteasome inhibitors Demethylating Agents Arsenicals Retinoids / Najla Al-Dawsari, Shannon Campbell and Francine Foss -- 21 Miscellaneous Reactions (L-Asparaginase, bleomycin, thalidomide, lenalidomide) / Katharina C. Kaehler, Christine B. Boers-Doets, Mario E. Lacouture and Axel Hauschild -- 22 Skin toxicities due to biotherapy (Interferon-[alpha]2b, Interleukin-2) / Axel Hauschild, Katharina Kaehler and Mario Lacouture -- 23 Monoclonal antibodies / Caroline Robert -- 24 Endocrine Agents / Katherine Szyfelbein and Mario Lacouture -- 25 Agents for the management of hematologic reactions: epotein alpha, darbopoetin, G-CSF, GM-CSF; oprelvekin; low molecular weight heparin; warfarin. / Mee-young Lee and Caroline C. Kim -- 26 RDERMATOLOGICAL PRINCIPLES AND PRACTICE IN ONCOLOGY / Rebecca Wong and Zahra Kassam -- 27 Hematopoietic stem cell transplantation and graft-versus-host disease / Stephanie Hu and Jonathan Cotliar -- 28 Extravasation Reactions / Seppo W. Langer -- 29 Topical Anticancer Therapies / Patricia L. Myskowski -- 30 Life-threatening (Serious) Dermatologic Adverse Events / Milan Anadkat -- 31 Dermatologic infections / Yevgeniy Balagula, Mario E. Lacouture and James I. Ito Section 5 -- 32 Late Dermatologic Conditions / Jennifer Namchoi Section 6 Dermatologic Practice in Oncology 33 Management Algorithms for Dermatologic Adverse Events / Alyx Rosen, Iris Amitay-Laish and Mario E. Lacouture -- 34 Dermatological therapeutics and formulations / Judy H. Borovicka, Jennifer R.S. Gordon, Ann Cameron Haley and Dennis P. West35 Dermatological Techniques and Procedures / Kishwer Nehal, Erica Lee and Robert Eilers -- 36 Appearance-Related Concerns in the Cancer Patient / Amy J. Derick.".
2013013054 title "Dermatology and the cancer patient : conditions of the skin, hair, and nails during cancer treatment and survivors / [edited by] Mario E. Lacouture.".
2013013054 type "text".